Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Mostrar otras versiones (1)

BACKGROUND: Low- and middle-income countries (LMICs) account for nearly 85% of the global cervical cancer burden, yet have the least access to high-performance screening. International guidelines recommend human papillomavirus testing (HPV) as primary screening, yet implementation is inhibited by th...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyo, Sikhulile, Ramogola-Masire, Doreen, Moraka, Natasha O., Tawe, Leabaneng, Noubary, Farzad, Motsumi, Kesego, Manowe, Godiraone, Zuze, Boitumelo, Radibe, Botshelo, Hungwe, Faith T. T., Mohammed, Terence, Maphorisa, Comfort, Shapiro, Roger, Gaseitsiwe, Simani, Luckett, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170707/
https://www.ncbi.nlm.nih.gov/pubmed/37165397
http://dx.doi.org/10.1186/s13027-023-00504-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170707/
https://www.ncbi.nlm.nih.gov/pubmed/37165397
http://dx.doi.org/10.1186/s13027-023-00504-z

Ejemplares similares